Brief: China NT Pharma Group To Buy 40% Stake In Hong Kong WD Pharmaceutical
10/07/2019 12:51
July 10 (Reuters) - China NT Pharma Group Company Ltd
1011.HK :
* CO TO BUY 40% STAKE IN HONG KONG WD PHARMACEUTICAL FROM WD
INVESTMENT
* MAXIMUM NUMBER OF CONSIDERATION SHARES TO BE ISSUED UNDER
ACQUISITION AGREEMENT IS 512.9 MILLION SHARES, REPRESENTS 21.22%
Source text for Eikon: urn:newsml:reuters.com:*:nHKS9h73yv
Further company coverage: 1011.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China NT Pharma
See all newsBrief: China NT Pharma Receives Cietac Beijing Arbitration Award On July 20
Brief: China NT Pharma Establishes Formal Whistleblowing Policy
Brief: China NT Pharma Group Says Zhang Bozhi Resigns As CEO
Brief: China NT Pharma Group Says Expected Loss For Year Further Reduced By HK$15.4 Million As Compared With Prior Guidance
Brief: China Nt Pharma Expects Net Loss Attributable Of RMB25 MLN To RMB30 MLN In FY